- Discriminating signal from noise: the biological variation of circulating calprotectin in serum and plasma(2024)
Auteurs: Xavier Bossuyt, Lieve Van Hoovels
- Reporting Likelihood Ratio in Autoimmune Serology: Just a Theory or Feasible in Practice?(2024)
Auteurs: Xavier Bossuyt, Lieve Van Hoovels
- Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP(2023)
Auteurs: Lieve Van Hoovels, Xavier Bossuyt
Pagina's: 1167 - 1198
- Circulating Calprotectin (cCLP) in autoimmune diseases(2023)
Auteurs: Lieve Van Hoovels, Xavier Bossuyt
- Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases(2023)
Auteurs: Lieve Van Hoovels, Xavier Bossuyt
- Serial measurement of circulating calprotectin as a prognostic biomarker in COVID-19 patients in intensive care setting(2023)
Auteurs: Louis Nevejan, Xavier Bossuyt, Lieve Van Hoovels
Pagina's: 494 - 502
- Arterial to end-tidal CO2 gradients during isocapnic hyperventilation(2023)
Auteurs: Lieve Van Hoovels, Arne Neyrinck, Marc Van De Velde
Pagina's: 311 - 317
- Serum free light chain analysis: persisting limitations with new kids on the block(2022)
Auteurs: Lieve Van Hoovels, Louis Nevejan
Pagina's: 1440 - 1448
- Harmonization in autoantibody testing.(2022)
Auteurs: Lieve Van Hoovels, Xavier Bossuyt
- Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care(2022)
Auteurs: Lieve Van Hoovels, Florent Vanstapel, Jan Verbakel
Pagina's: 329 - 336